Literature DB >> 19917759

Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients.

James R Johnson1, Brian Johnston, Connie Clabots, Michael A Kuskowski, Swaroop Pendyala, Chitrita Debroy, Bogdan Nowicki, James Rice.   

Abstract

Among 40 Escherichia coli urine isolates from renal transplant recipients (Galveston, TX, 2003 to 2005), sequence type ST131 (O25:H4) was highly prevalent (representing 35% of isolates overall and 60% of fluoroquinolone-resistant isolates), virulent appearing, antimicrobial resistant (but extended-spectrum-cephalosporin susceptible), and associated with black race. Pulsotypes were diverse; some were linked to other locales. ST131 emerged significantly during the study period. These findings suggest that E. coli ST131 may constitute an important new multidrug-resistant threat to renal transplant recipients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19917759      PMCID： PMC2798475          DOI： 10.1128/AAC.01089-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.

Authors:  Elaine O Petrof; David N Schwartz; John P Quinn
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

Review 2.  Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic.

Authors:  N E Tolkoff-Rubin; R H Rubin
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 3.  Infectious disease complications of renal transplantation.

Authors:  R H Rubin
Journal:  Kidney Int       Date:  1993-07       Impact factor: 10.612

4.  Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.

Authors:  James R Johnson; Michael A Kuskowski; Abby Gajewski; Daniel F Sahm; James A Karlowsky
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

5.  Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors.

Authors:  J C Rice; T Peng; Y-F Kuo; S Pendyala; L Simmons; J Boughton; K Ishihara; S Nowicki; B J Nowicki
Journal:  Am J Transplant       Date:  2006-07-25       Impact factor: 8.086

6.  Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.

Authors:  William J Burman; Peter E Breese; Barbara E Murray; Kavindra V Singh; Holly A Batal; Thomas D MacKenzie; John W Ogle; Michael L Wilson; Randall R Reves; Philip S Mehler
Journal:  Am J Med       Date:  2003-10-01       Impact factor: 4.965

7.  Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.

Authors:  James R Johnson; Michael A Kuskowski; Krista Owens; Abby Gajewski; Patricia L Winokur
Journal:  J Infect Dis       Date:  2003-08-15       Impact factor: 5.226

8.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.

Authors:  Véronique Leflon-Guibout; Jorge Blanco; Karim Amaqdouf; Azucena Mora; Louis Guize; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

10.  Urinary tract infections in kidney transplant recipients.

Authors:  D E Ramsey; W T Finch; A G Birtch
Journal:  Arch Surg       Date:  1979-09
View more
  33 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.

Authors:  James R Johnson; Stephen B Porter; Paul Thuras; Timothy J Johnson; Lance B Price; Veronika Tchesnokova; Evgeni V Sokurenko
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

3.  Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.

Authors:  James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

4.  Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death.

Authors:  Robert C Owens; James R Johnson; Patricia Stogsdill; Lonny Yarmus; Karen Lolans; John Quinn
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

Review 5.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

6.  Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.

Authors:  Lakshmi Chandramohan; Paula A Revell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

7.  Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.

Authors:  Azucena Mora; Alexandra Herrera; Rosalia Mamani; Cecilia López; María Pilar Alonso; Jesús E Blanco; Miguel Blanco; Ghizlane Dahbi; Fernando García-Garrote; Julia María Pita; Amparo Coira; María Isabel Bernárdez; Jorge Blanco
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

Review 8.  Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Authors:  Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

9.  Complete sequence of pJIE186-2, a plasmid carrying multiple virulence factors from a sequence type 131 Escherichia coli O25 strain.

Authors:  Zhiyong Zong
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

10.  Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.

Authors:  Michael A Liss; Ellena M Peterson; Brian Johnston; Kathryn Osann; James R Johnson
Journal:  Urology       Date:  2013-01-17       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.